{ "as_of": "2026-11-06", "cmr": "ca-cm-kg/TSXV/RX", "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.", "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# BioSyent Inc. (TSXV: RX) — research page\n\nAs of 2026-11-06 · ca-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is BioSyent Inc., listed on the TSXV under ticker RX, with ISIN CA0906901081; its LEI is not on the record because the ISIN is not in the GLEIF ISIN-to-LEI mapping file. Its security type is Corporate, its segment is not on the record, its sector is Life Sciences, and its jurisdiction is Canada (federal, CBCA). Its listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 28 filings on 22 filing days in the twelve months to 2026-11-06, comprising 9 corporate action, 1 exchange bulletin, 8 financial statement and 10 newswire release filings. The median gap between filing days is 10 days, against a TSXV median of 19 days and a Life Sciences median of 17.5 days. The days from the latest filing to the record date are 17, against a TSXV median of 17.0 days and a Life Sciences median of 14 days. The latest filing is dated 2026-10-20 and is a newswire release. The TSXV median filings count is 9 and the Life Sciences median filings count is 7.0.\n\n## Auditor\n\nThe auditor of record is MNP LLP, whose location is not on the record. The record holds no auditor changes.\n\n## Events and halts\n\nThe record holds no delisting, domicile change, listing, name change or segment move lines. The halt flag is listed, not halted.\n\n## Orderability\n\nUnder the rule version acm-68000/ca/kyp-know-your-product-ni-31-103/r1, with chapter as of 2026-11-04, the outcome for paragraph (o) of the definition is signal ACM-200 and is determinable. The outcome for paragraph (q) of the definition is signal ACM-200 and is determinable.\n\n## Coverage\n\nNo research houses were found on the investor-relations pages read, and the count is 0.\n\n## Open research\n\nNo openly published research notes were found, and the count is 0.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe vintage is not sealed. The record holds no sealed issuer years and no market earliest sealed date. The live record began on 2026-09-10. Years 2021 through 2026 are sealed in the store but are not served as of a date, and the as-of door answers not_sealed.\n\n## Sources\n\n8 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.tsx.com/json/company-directory/search/tsxv/^* (identity.exchange)\n- https://www.marketscreener.com/news/biosyent-inc-tsxv-rx-completed-the-acquisition-of-oral-science-inc-from-a-group-of-shareholders-f-ce7e5cdddf8eff21 (identity.isin)\n- https://www.biosyent.com/wp-content/uploads/2026/03/BioSyent-Inc.-2025-Financial-Statements.pdf (identity.jurisdiction)\n- https://www.tsx.com/en/resource/571 (identity.sector)\n- https://mcp.ca-cm-kg.ai/events/TSXV/RX (the disclosure lines)\n- https://iiroc.mediaroom.com/index.php?s=2429&l=100 (the halt flag)\n- https://mcp.ca-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://mcp.ca-cm-kg.ai/record/TSXV/RX (the record)\n", "market": "CA", "node": "ca-cm-kg", "numbers": { "as_of_depth": { "issuer_years_sealed": [], "live_record_began": "2026-09-10", "node_history_from": null, "node_years_sealed": [], "note": "6 years are sealed in the CA store; their Replay split is not built, so the as-of door answers not_sealed and the record is the live record as of 2026-11-06", "record_version": 1, "sealed": false, "store_years_sealed_not_served": [ "2021", "2022", "2023", "2024", "2025", "2026" ] }, "auditor": { "auditor": { "read_by": "Tavily regex", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.biosyent.com/wp-content/uploads/2026/03/BioSyent-Inc.-2025-Financial-Statements.pdf", "state": "sourced", "value": "MNP LLP" }, "auditor_firm_id": { "market": "CA", "state": "not_on_record" }, "auditor_location": { "market": "CA", "state": "not_on_record" }, "changes": [] }, "cmr": "ca-cm-kg/TSXV/RX", "coverage": { "count": 0, "houses": [], "pages_checked": [], "read_by": "Perplexity sonar (search) · page read by this rail", "read_date": "2026-11-12", "since": null, "state": "none_found" }, "disclosure": { "against": { "exchange": { "issuers": 1427, "median_cadence_gap_days": 19, "median_filings": 9, "median_latency_days": 17, "name": "TSXV" }, "sector": { "issuers": 200, "median_cadence_gap_days": 17.5, "median_filings": 7, "median_latency_days": 14, "name": "Life Sciences" } }, "by_type": { "corporate_action": 9, "exchange_bulletin": 1, "financial_statement": 8, "newswire_release": 10 }, "cadence_median_gap_days": 10, "filing_days": 22, "filings": 28, "latency_days": 17, "latest": [ { "category": null, "date": "2026-10-20", "source": "https://www.globenewswire.com/news-release/2026/10/20/3385024/0/en/biosyent-to-present-at-planet-microcap-toronto.html", "title": "BioSyent to Present at Planet MicroCap Toronto", "type": "newswire_release" }, { "category": null, "date": "2026-09-25", "source": "https://www.globenewswire.com/news-release/2026/09/25/3369156/0/en/biosyent-named-as-one-of-canada-s-top-growing-companies-2026-by-the-globe-and-mail.html", "title": "BioSyent Named as One of Canada’s Top Growing Companies", "type": "newswire_release" }, { "category": null, "date": "2026-08-24", "source": "http://apps.tmx.com/TSXVenture/TSXVentureHttpController?GetPage=NoticesContents&PO_ID=&NOTICE_ID=320687&CORRECTION_FLG=N&HC_FLAG1=checked", "title": "TSXV bulletin: DECLARATION OF DIVIDEND (Dividend)", "type": "corporate_action" }, { "category": null, "date": "2026-08-20", "source": "https://www.globenewswire.com/news-release/2026/08/20/3348841/0/en/biosyent-releases-financial-results-for-q2-and-h1-2026.html", "title": "BioSyent Releases Financial Results for Q2 and H1 2026", "type": "financial_statement" }, { "category": null, "date": "2026-08-20", "source": "https://www.globenewswire.com/news-release/2026/08/20/3348837/0/en/biosyent-declares-third-quarter-2026-dividend.html", "title": "BioSyent Declares Third Quarter 2026 Dividend", "type": "corporate_action" } ], "latest_filing_date": "2026-10-20", "read": "the node's event lines (list_events_since), as get_filings serves them", "source": "https://mcp.ca-cm-kg.ai/events/TSXV/RX", "window": { "from": "2025-11-06", "to": "2026-11-06" } }, "identity": { "exchange": { "read_by": "tsx.com company directory (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.tsx.com/json/company-directory/search/tsxv/^*", "state": "sourced", "value": "TSXV" }, "isin": { "read_by": "Tavily search + regex extraction from page text", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.marketscreener.com/news/biosyent-inc-tsxv-rx-completed-the-acquisition-of-oral-science-inc-from-a-group-of-shareholders-f-ce7e5cdddf8eff21", "state": "sourced", "value": "CA0906901081" }, "jurisdiction": { "read_by": "Tavily search + regex extraction from page text", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.biosyent.com/wp-content/uploads/2026/03/BioSyent-Inc.-2025-Financial-Statements.pdf", "state": "sourced", "value": "Canada (federal, CBCA)" }, "lei": { "market": "CA", "reason": "ISIN not in the GLEIF ISIN-to-LEI mapping file", "state": "not_on_record" }, "name": { "read_by": "tsx.com company directory (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.tsx.com/json/company-directory/search/tsxv/^*", "state": "sourced", "value": "BioSyent Inc." }, "sector": { "read_by": "TMX listed-companies workbook (exchange list, monthly; data month named in the source column)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.tsx.com/en/resource/571 (tsx-and-amp-tsxv-listed-companies-2026-08-14-en.xlsx, data as of 31-Jul-2026)", "state": "sourced", "value": "Life Sciences" }, "security_type": { "read_by": "TMX listed-companies workbook (exchange list, monthly; data month named in the source column)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.tsx.com/en/resource/571 (tsx-and-amp-tsxv-listed-companies-2026-08-14-en.xlsx, data as of 31-Jul-2026)", "state": "sourced", "value": "Corporate" }, "segment": { "market": "CA", "state": "not_on_record" }, "ticker": { "read_by": "tsx.com company directory (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.tsx.com/json/company-directory/search/tsxv/^*", "state": "sourced", "value": "RX" }, "website": { "market": "CA", "state": "not_on_record" } }, "licensed": { "columns": [ "licensor", "entitlement", "title", "date", "source" ], "rows": [], "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded." }, "lifecycle": { "delisting": [], "domicile_change": [], "listing": [], "name_change": [], "segment_move": [] }, "market": "CA", "node": "ca-cm-kg", "numbers_hash": "sha256:0adc976b081e5e9a5ea6aae39558706947e19a91c24fecfa7c33ca54ca3e358f", "open_research": { "read_date": "2026-11-12", "rows": [], "state": "none_found" }, "orderability": { "chapter_as_of": "2026-11-04", "client_categories": [ "Paragraph (o) of the definition", "Paragraph (q) of the definition" ], "outcomes": { "Paragraph (o) of the definition": { "determinable": true, "signal": "ACM-200" }, "Paragraph (q) of the definition": { "determinable": true, "signal": "ACM-200" } }, "read": { "basis": "one live read per instrument class, halt state and client category on this market; this issuer's group", "chapter": "https://mcp.ca-cm-kg.ai/book/aio.json", "door": "https://mcp.ca-cm-kg.ai/mcp", "tool": "get_orderability" }, "rule_version": "acm-68000/ca/kyp-know-your-product-ni-31-103/r1", "section": "ca.aio.v11" }, "record": { "as_of": "2026-11-06", "url": "https://mcp.ca-cm-kg.ai/record/TSXV/RX", "version": 1 }, "schema": "research-numbers v0.1 (USR-01, 2026-11-11)", "status": { "read_date": "2026-11-08", "source": "https://iiroc.mediaroom.com/index.php?s=2429&l=100", "value": "listed, not halted" } }, "numbers_hash": "sha256:0adc976b081e5e9a5ea6aae39558706947e19a91c24fecfa7c33ca54ca3e358f", "path": "/ca/TSXV/RX", "schema": "research-page v0.1 (USR-02, 2026-11-11)", "sections": [ { "id": "identity", "text": "The issuer is BioSyent Inc., listed on the TSXV under ticker RX, with ISIN CA0906901081; its LEI is not on the record because the ISIN is not in the GLEIF ISIN-to-LEI mapping file. Its security type is Corporate, its segment is not on the record, its sector is Life Sciences, and its jurisdiction is Canada (federal, CBCA). Its listing status is listed, not halted.", "title": "Identity and listing" }, { "id": "disclosure", "text": "The record holds 28 filings on 22 filing days in the twelve months to 2026-11-06, comprising 9 corporate action, 1 exchange bulletin, 8 financial statement and 10 newswire release filings. The median gap between filing days is 10 days, against a TSXV median of 19 days and a Life Sciences median of 17.5 days. The days from the latest filing to the record date are 17, against a TSXV median of 17.0 days and a Life Sciences median of 14 days. The latest filing is dated 2026-10-20 and is a newswire release. The TSXV median filings count is 9 and the Life Sciences median filings count is 7.0.", "title": "The disclosure read" }, { "id": "auditor", "text": "The auditor of record is MNP LLP, whose location is not on the record. The record holds no auditor changes.", "title": "Auditor" }, { "id": "events", "text": "The record holds no delisting, domicile change, listing, name change or segment move lines. The halt flag is listed, not halted.", "title": "Events and halts" }, { "id": "orderability", "text": "Under the rule version acm-68000/ca/kyp-know-your-product-ni-31-103/r1, with chapter as of 2026-11-04, the outcome for paragraph (o) of the definition is signal ACM-200 and is determinable. The outcome for paragraph (q) of the definition is signal ACM-200 and is determinable.", "title": "Orderability" }, { "id": "coverage", "text": "No research houses were found on the investor-relations pages read, and the count is 0.", "title": "Coverage" }, { "id": "open_research", "text": "No openly published research notes were found, and the count is 0.", "title": "Open research" }, { "id": "licensed", "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.", "title": "Licensed" }, { "id": "depth", "text": "The vintage is not sealed. The record holds no sealed issuer years and no market earliest sealed date. The live record began on 2026-09-10. Years 2021 through 2026 are sealed in the store but are not served as of a date, and the as-of door answers not_sealed.", "title": "As-of depth" }, { "id": "sources", "text": "8 source pages are named on this page; every value above carries its own source page and read date in the numbers.", "title": "Sources" } ], "sources": [ { "for": "identity.exchange", "source": "https://www.tsx.com/json/company-directory/search/tsxv/^*" }, { "for": "identity.isin", "source": "https://www.marketscreener.com/news/biosyent-inc-tsxv-rx-completed-the-acquisition-of-oral-science-inc-from-a-group-of-shareholders-f-ce7e5cdddf8eff21" }, { "for": "identity.jurisdiction", "source": "https://www.biosyent.com/wp-content/uploads/2026/03/BioSyent-Inc.-2025-Financial-Statements.pdf" }, { "for": "identity.sector", "source": "https://www.tsx.com/en/resource/571" }, { "for": "the disclosure lines", "source": "https://mcp.ca-cm-kg.ai/events/TSXV/RX" }, { "for": "the halt flag", "source": "https://iiroc.mediaroom.com/index.php?s=2429&l=100" }, { "for": "the orderability chapter", "source": "https://mcp.ca-cm-kg.ai/book/aio.json" }, { "for": "the record", "source": "https://mcp.ca-cm-kg.ai/record/TSXV/RX" } ], "title": "BioSyent Inc. (RX) — research page", "writer": { "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers", "engine": "claude-haiku-5-5" } }